We also find BNC2 is down-regulated in 9 of 28 cancer types, including breast cancer (Fig 8A), and trends toward down-regulation in a further seven, whereas up-regulation is observed in six cancer types, only three of which being statistically significant (Fig S10A). Here, BNC2 is linked to breast carcinoma.